JAMA ONCOLOGY

Edit Your Profile

JAMA ONCOLOGY Journal

publication venue for

Efficacy of Treatment With Armodafinil for Cancer-Related Fatigue in Patients With High-grade Glioma A Phase 3 Randomized Clinical Trial. 8:259-267. 2022
Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-Adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study. 5:1749-1768. 2019
Estimating Survival in Patients With Lung Cancer and Brain Metastases An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA). 3:827-831. 2017
Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era A Correlative Analysis Based on NRG Oncology RTOG 0525. 3:784-792. 2017
Quality Assessment of a Systematic Review for HIV Infection and Advanced-Stage Cancer 2019
Regarding the Congruence between 2 Circulating Tumor DNA Sequencing Assays 2018
Brain Metastases in Lung Cancer With Targetable Mutations: Should We Allow Targeted Treatment in Prognostic Indices? Reply 2018
Global Consensus on the Management of Primary Localized Chordoma 2026
Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide An Analysis From the NRG Oncology/RTOG 0424 Trial 2018
The Changing Role of Whole-Brain Radiotherapy Demise or Time for Selective Usage? 2017
The Changing Role of Whole-Brain Radiotherapy: Demise or Time for Selective Usage? (vol 3, pg 1021, 2017) 2017

category

ONCOLOGY Category

International Standard Serial Number (ISSN)

2374-2437

Electronic International Standard Serial Number (EISSN)

2374-2445

journal abbreviation

JAMA ONCOL